Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-945-6 | CAS number: 101-48-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 Oct - 06 Nov 2015
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- occlusive conditions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- 1987
- Deviations:
- yes
- Remarks:
- occlusive instead of semi-occlusive conditions
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 1,1-dimethoxy-2-phenylethane
- EC Number:
- 202-945-6
- EC Name:
- 1,1-dimethoxy-2-phenylethane
- Cas Number:
- 101-48-4
- Molecular formula:
- C10H14O2
- IUPAC Name:
- (2,2-dimethoxyethyl)benzene
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD), SPF
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8 weeks (males), 9 weeks (females)
- Weight at study initiation: 270.3 - 285.4 g (males), 215.4 - 248.0 (females)
- Housing: individually in stainless wire mech cages (260W x 350D x 210H mm)
- Diet: Teklad Certified Irradiated Global 18% Protein Rodent Diet 2918C (Harlan Laboratories, Inc., USA), ad libitum
- Water: public tap water filtered and irradiated by ultraviolet light, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.9 - 22.6
- Humidity (%): 46.9 - 56.0
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- A preliminary study was conducted to select the dose level for the main study.
TEST SITE
- Area of exposure: skin of the subscapular dorsal surface (approx. 5 cm x 6 cm)
- Type of wrap if used: After the application of the test substance to a lint tape, the application site was covered with the lint tape and plastic film. The back of the animals was over-wrapped with Soft Cloth Tape with Liner (5 cm width) and surgical tape.The application site of control animals was covered with the lint tape, plastic film and Soft Cloth Tape with Liner and surgical tape in the same manner as dosed animals.
REMOVAL OF TEST SUBSTANCE
- Washing: Any residual test substance was removed using absorbent cotton moistened with tepid water.
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount applied: 4.98 mL/kg bw
- Constant concentration used: yes - Duration of exposure:
- 24 h
- Doses:
- Preliminary study: 5000 mg/kg bw
Main study: 0 and 5000 mg/kg bw - No. of animals per sex per dose:
- Preliminary study: 1 male and 1 female
Main study: 5 males and 5 females - Control animals:
- yes, concurrent no treatment
- Details on study design:
- Preliminary study:
- Duration of observation period following administration: 3 days
- Frequency of observations: Individual body weights were recorded on the day of treatment and on Day 3.
- Necropsy of survivors performed: no
Main study:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed 30 min and 1, 2, 4 and 6 h after dosing and thereafter once daily for 14 days. Individual body weights were recorded prior to dosing on Day 0 and on Days 3, 7 and on the day of necropsy, Day 14.
- Necropsy of survivors performed: yes - Statistics:
- Statistical analysis was performed using SAS Program (version 9.3). Body weights were analyzed utilizing Folded-F test for homogeneity of variance (significance level: 0.05). Student t-test was employed on homogeneous data (significance level: 0.05) or Aspin-Welch t-test was employed on heterogeneous data (significance level: 0.05) for confirming significance (significance levels: 0.05 and 0.01, two-tailed), respectively.
Results and discussion
- Preliminary study:
- No deaths or clinical signs of toxicity were noted at 5000 mg/kg bw throughout the 3-day observation period. The dose level selected for the main study was therefore 5000 mg/kg bw.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred during the study period of the main study.
- Clinical signs:
- other: No signs of systemic toxicity were noted during the main study.
- Gross pathology:
- No abnormalities were noted at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- In this acute dermal toxicity study a LD50 value > 5000 mg/kg bw in male and female rats was found.
- Executive summary:
The acute dermal toxicity of the test substance was assessed in a study according to OECD Guideline 402 and in compliance with GLP (2015b). In a preliminary study, 1 male and female rat, respectively, were treated dermally with 5000 mg/kg bw test substance. Since no mortality was observed at 5000 mg/kg bw this dose level was selected for the main study. In the main study, 5 male and female rats, respectively, were treated dermally with test substance under occlusive conditions for 24 hours. Additionally, a control group consisting of 5 male and female rats, respectively, was treated in the same manner as dosed animals except that the test substance was omitted. Animals were subjected for mortality, general condition and clinical signs at 0.5, 1, 2, 4 and 6 hours after dosing on Day 0 and subsequently once daily for 14 days. Individual body weights were recorded prior to application of the test substance on Day 0 and on Days 3, 7 and 14 days after treatment. Macroscopic examination was performed in the end of the observation period at terminal sacrifice. There was no mortality and no effects on body weight gain during the 14-day observation period. No clinical abnormalities were evident in any animal throughout the study. Macroscopic postmortem examination did not reveal any abnormalities. The LD50 value for dermal toxicity was considered to be > 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.